172 related articles for article (PubMed ID: 21393379)
1. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.
Chavez-MacGregor M; Zhao H; Kroll M; Fang S; Zhang N; Hortobagyi GN; Buchholz TA; Shih YC; Giordano SH
Ann Oncol; 2011 Nov; 22(11):2394-2402. PubMed ID: 21393379
[TBL] [Abstract][Full Text] [Related]
2. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.
Chavez-MacGregor M; Zhao H; Fang S; Srokowski TP; Hortobagyi GN; Giordano SH
Cancer; 2011 Aug; 117(16):3641-9. PubMed ID: 21656514
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of arterial thromboembolism in older men with breast cancer.
Reiner AS; Navi BB; DeAngelis LM; Panageas KS
Breast Cancer Res Treat; 2017 Dec; 166(3):903-910. PubMed ID: 28836029
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
5. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
[TBL] [Abstract][Full Text] [Related]
6. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.
Hill TD; Khamis HJ; Tyczynski JE; Berkel HJ
Ann Epidemiol; 2005 Nov; 15(10):773-80. PubMed ID: 16257362
[TBL] [Abstract][Full Text] [Related]
7. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
Hershman DL; Buono DL; Malin J; McBride R; Tsai WY; Neugut AI
J Natl Cancer Inst; 2009 Dec; 101(23):1633-41. PubMed ID: 19903808
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.
Papaxoinis G; Kamposioras K; Germetaki T; Weaver JMJ; Stamatopoulou S; Nasralla M; Kordatou Z; Owen-Holt V; Anthoney A; Mansoor W
Acta Oncol; 2018 Jun; 57(6):790-798. PubMed ID: 29308947
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolic Events in Patients with Testicular Germ Cell Tumours Are Predominantly Triggered by Advanced Disease and by Central Venous Access Systems.
Dieckmann KP; Marghawal D; Pichlmeier U; Wülfing C
Urol Int; 2021; 105(3-4):257-263. PubMed ID: 33333524
[TBL] [Abstract][Full Text] [Related]
10. Affluence and Breast Cancer.
Lehrer S; Green S; Rosenzweig KE
Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
[TBL] [Abstract][Full Text] [Related]
11. Laterality of breast cancer in the United States.
Weiss HA; Devesa SS; Brinton LA
Cancer Causes Control; 1996 Sep; 7(5):539-43. PubMed ID: 8877052
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study.
Kim TH; Choi JH; Jeon SM; Choi YW; Kwon M; Lee HW; Kang SY; Ahn MS; Son SY; Hur H; Han SU; Sheen SS
Gastric Cancer; 2023 Nov; 26(6):1012-1019. PubMed ID: 37648892
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M
Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294
[TBL] [Abstract][Full Text] [Related]
14. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.
Moore RA; Adel N; Riedel E; Bhutani M; Feldman DR; Tabbara NE; Soff G; Parameswaran R; Hassoun H
J Clin Oncol; 2011 Sep; 29(25):3466-73. PubMed ID: 21810688
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab-related cardiotoxicity among older patients with breast cancer.
Chavez-MacGregor M; Zhang N; Buchholz TA; Zhang Y; Niu J; Elting L; Smith BD; Hortobagyi GN; Giordano SH
J Clin Oncol; 2013 Nov; 31(33):4222-8. PubMed ID: 24127446
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.
Debourdeau P; Espié M; Chevret S; Gligorov J; Elias A; Dupré PF; Desseaux K; Kalidi I; Villiers S; Giachetti S; Frere C; Farge D
Cancer Med; 2017 Nov; 6(11):2732-2744. PubMed ID: 28980454
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy.
Ammann EM; Jones MP; Link BK; Carnahan RM; Winiecki SK; Torner JC; McDowell BD; Fireman BH; Chrischilles EA
Blood; 2016 Jan; 127(2):200-7. PubMed ID: 26443622
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in treatment and survival of male breast cancer.
Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
[TBL] [Abstract][Full Text] [Related]
19. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
20. Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.
Thomas A; Khan SA; Chrischilles EA; Schroeder MC
JAMA Surg; 2016 May; 151(5):424-31. PubMed ID: 26629881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
